Greedy Insider
ORKA Insider Trades and Greediness Scores
Oruka Therapeutics, Inc. (ORKA) insider trades: since Dec 19, 2025, Greedy Insider recorded 0 open-market buys and 122 sales on Form 4 from 7 insiders. The strongest recent filing scored 93 (Strong).
Who bought and who sold
Across the last 122 scoreable Form 4 transactions in ORKA, 0 were open-market purchases and 122 were sales. The table lists the most recent filings with each one's Greediness Score, so the structurally unusual trades are easy to spot first.
| Insider | Role | Type | Shares | Date | Score | ||
|---|---|---|---|---|---|---|---|
| Quinlan Paul T | General Counsel | Sell | 400.0 | 29960.28 | 2026-10-20 | 50 | View |
| Quinlan Paul T | General Counsel | Sell | 500.0 | 38059.0 | 2026-10-20 | 50 | View |
| Quinlan Paul T | General Counsel | Sell | 1000.0 | 77205.0 | 2026-10-20 | 50 | View |
| Quinlan Paul T | General Counsel | Sell | 4100.0 | 323036.94 | 2026-10-20 | 58 | View |
| Quinlan Paul T | General Counsel | Sell | 3000.0 | 238473.6 | 2026-10-20 | 56 | View |
| Goncalves Joana | Chief Medical Officer | Sell | 2853.0 | 210806.45 | 2026-10-15 | 81 | View |
| Goncalves Joana | Chief Medical Officer | Sell | 1847.0 | 137956.86 | 2026-10-15 | 78 | View |
| Goncalves Joana | Chief Medical Officer | Sell | 1400.0 | 105676.76 | 2026-10-15 | 76 | View |
| Goncalves Joana | Chief Medical Officer | Sell | 700.0 | 53665.64 | 2026-10-15 | 72 | View |
| Goncalves Joana | Chief Medical Officer | Sell | 200.0 | 15542.0 | 2026-10-15 | 68 | View |
The strongest recent filing
Goncalves Joana (Chief Medical Officer) sold 5,064 shares of Oruka Therapeutics, Inc. on Jun 15, 2026, a filing that scored 93 (Strong). It scored Strong because a senior insider was trading and several insiders moved the same way within a week. The score describes the filing, not future returns. This is not investment advice.
Cluster activity
A cluster buy is present: 6 insiders (Agarwal Arjun, Goncalves Joana, Klein Lawrence Otto, Sandler Laura Lee) traded ORKA the same direction within a 7-day window. Shared conviction is a stronger structural signal than a lone trade.
How this compares with Oruka Therapeutics, Inc.'s own history
Open-market buys make up 0% of the 122 scoreable ORKA transactions on record between Dec 19, 2025 and Oct 20, 2026. Comparing a filing with the company's own buy/sell mix is how you tell a routine disposal from an unusual accumulation.
Methodology and sources
Scores come from six published, user-adjustable factors (insider role, cluster activity, trade size versus the insider's own history, position impact, filing urgency, and direct versus indirect ownership). The score describes the filing, not future returns. This is not investment advice.
Key facts
- Scoreable Form 4 transactions on record: 122
- Open-market buys: 0
- Sales: 122
- Distinct insiders: 7
- Strongest recent Greediness Score: 93 (Strong)
Primary sources
Related
- Strongest filing
- ORKA in the live feed
- How the Greediness Score works
- What is a cluster buy?
- Form 4 transaction codes
The score describes the filing, not future returns. This is not investment advice.